✦ LIBER ✦

Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats

✍ Scribed by Heredia-Ortiz, Roberto; Bouchard, Michèle

Book ID: 121600911
Publisher: Springer
Year: 2013
Tongue: English
Weight: 388 KB
Volume: 40
Category: Article
ISSN: 1573-8744
DOI: 10.1007/s10928-013-9338-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modeling of the internal kinetics of ben

Modeling of the internal kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker from rat data

✍ R. Heredia-Ortiz; M. Bouchard; C. Marie-Desvergne; C. Viau; A. Maître 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Kinetics of benzo(a)pyrene and 3-hydroxy

Kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene in relation to DNA adducts formation in rat tissues following intravenous administration of the parent compound

✍ Caroline Marie; Michèle Bouchard; Ross Thuot; Jean-Luc Ravanat; Anne Maître; Cla 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Comparison and evaluation of pharmacokin

Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model

✍ Anne E. Loccisano; Jerry L. Campbell Jr; John L. Butenhoff; Melvin E. Andersen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 901 KB

Evaluation of DNA Adducts, DNA and RNA O

Evaluation of DNA Adducts, DNA and RNA Oxidative Lesions, and 3-Hydroxybenzo( a )pyrene as Biomarkers of DNA Damage in Lung Following Intravenous Injection of the Parent Compound in Rats

✍ Marie-Desvergne, Caroline; Maître, Anne; Bouchard, Michèle; Ravanat, Jean-Luc; 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 142 KB

Investigation of 5-FU disposition after

Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

✍ Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5‐FU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5‐FU and 5‐F